Strategies to reduce toxicities and improve outcomes in renal transplant recipientsLO, Agnes; ALLOWAY, Rita R.Pharmacotherapy. 2002, Vol 22, Num 3, pp 316-328, issn 0277-0008Article

Renal transplantation in high-risk patientsWEIMERT, Nicole A; ALLOWAY, Rita R.Drugs (Basel). 2007, Vol 67, Num 11, pp 1603-1627, issn 0012-6667, 25 p.Article

How can donors with a previous malignancy be evaluated? : Liver transplantationBUELL, Joseph F; ALLOWAY, Rita R; WOODLE, E. Steve et al.Journal of hepatology. 2006, Vol 45, Num 4, pp 503-507, issn 0168-8278, 5 p.Article

YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa studyOSAMA GABER, A; MULGAONKAR, Shamkant; LIPSHUTZ, Gerald et al.Clinical transplantation. 2011, Vol 25, Num 4, pp 523-533, issn 0902-0063, 11 p.Article

Once-daily tacrolimus extended release formulation : Experience at 2 years postconversion from a prograf-based regimen in stable liver transplant recipientsFLORMAN, Sander; ALLOWAY, Rita; DHADDA, Shobha et al.Transplantation. 2007, Vol 83, Num 12, pp 1639-1642, issn 0041-1337, 4 p.Article

Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulationsALLOWAY, Rita; VANHAECKE, Johan; KARPF, Carmen et al.The Journal of heart and lung transplantation. 2011, Vol 30, Num 9, pp 1003-1010, issn 1053-2498, 8 p.Article

Donors with central nervous system malignancies: Are they truly safe? CommentaryBUELL, Joseph F; TROFE, Jennifer; SETHURAMAN, Gopalan et al.Transplantation. 2003, Vol 76, Num 2, pp 280-281, issn 0041-1337, 6 p.Article

Proteasome inhibitor-based therapy for antibody-mediated rejectionCARLIN WALSH, R; ALLOWAY, Rita R; GIRNITA, Alin L et al.Kidney international. 2012, Vol 81, Num 11, pp 1067-1074, issn 0085-2538, 8 p.Article

Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipientsALLOWAY, Rita; STEINBERG, Steven; WISEMANDLE, Kathleen et al.Transplantation. 2007, Vol 83, Num 12, pp 1648-1651, issn 0041-1337, 4 p.Article

Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantationALEXANDER, J. Wesley; GOODMAN, Hope R; HANAWAY, Michael et al.Transplant international. 2006, Vol 19, Num 4, pp 295-302, issn 0934-0874, 8 p.Article

Random-Effects Linear Modeling and Sample Size Tables for Two Special Crossover Designs of Average Bioequivalence Studies: The Four-Period, Two-Sequence, Two-Formulation and Six-Period, Three-Sequence, Three-Formulation DesignsDIAZ, Francisco J; BERG, Michel J; KREBILL, Ron et al.Clinical pharmacokinetics. 2013, Vol 52, Num 12, pp 1033-1043, issn 0312-5963, 11 p.Article

Transmission of donor cancer into cardiothoracic transplant recipients. DiscussionBUELL, Joseph F; TROFE, Jennifer; KOFFRON, Alan et al.Surgery. 2001, Vol 130, Num 4, pp 660-668, issn 0039-6060Conference Paper

A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysisSTRATTA, Robert J; ALLOWAY, Rita R; HODGE, Ernest et al.Clinical transplantation. 2002, Vol 16, Num 1, pp 60-68, issn 0902-0063Article

Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: Primary endpoint analysis of a multicenter, randomized studySTRATTA, Robert J; ALLOWAY, Rita R; LO, Agnes et al.Transplantation. 2003, Vol 75, Num 8, pp 1260-1266, issn 0041-1337, 7 p.Conference Paper

The effect of gut metabolism on tacrolimus bioavailability in renaltransplant recipientsTUTEJA, Sony; ALLOWAY, Rita R; JOHNSON, Julie A et al.Transplantation. 2001, Vol 71, Num 9, pp 1303-1307, issn 0041-1337Article

Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect : Potential clinical implicationsWEIMERT, Nicole A; DEROTTE, Maurits; ALLOWAY, Rita R et al.Therapeutic drug monitoring. 2007, Vol 29, Num 2, pp 141-149, issn 0163-4356, 9 p.Article

Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients : a pilot studyROGERS, Christin C; ALLOWAY, Rita R; ALEXANDER, J. Wesley et al.Clinical transplantation. 2008, Vol 22, Num 3, pp 281-291, issn 0902-0063, 11 p.Article

Risk assessment of immunosuppressive therapy in facial transplantationVASILIC, Dalibor; ALLOWAY, Rita R; BARKER, John H et al.Plastic and reconstructive surgery (1963). 2007, Vol 120, Num 3, pp 657-668, issn 0032-1052, 12 p.Article

Proteasome Inhibition for Antibody-Mediated Allograft RejectionSADAKA, Basma; ALLOWAY, Rita R; SHIELDS, Adele R et al.Seminars in hematology. 2012, Vol 49, Num 3, pp 263-269, issn 0037-1963, 7 p.Article

De Novo Cancers Arising in Organ Transplant Recipients are Associated With Adverse Outcomes Compared With the General PopulationYUN MIAO; EVERLY, Jason J; GROSS, Thomas G et al.Transplantation. 2009, Vol 87, Num 9, pp 1347-1359, issn 0041-1337, 13 p.Article

A Prospective Trial of a Steroid-Free/Calcineurin Inhibitor Minimization Regimen in Human Leukocyte Antigen (HLA)-Identical Live Donor Renal TransplantationWALKER, Jennifer K; ALLOWAY, Rita R; ROY-CHAUDHURY, Prabir et al.Transplantation. 2009, Vol 87, Num 3, pp 408-414, issn 0041-1337, 7 p.Article

Composite tissue allotransplantation : a review of relevant immunological issues for plastic surgeonsWHITAKER, Lain S; DUGGAN, Eileen M; ALLOWAY, Rita R et al.Journal of plastic, reconstructive & aesthetic surgery. 2008, Vol 61, Num 5, pp 481-492, issn 1748-6815, 12 p.Article

Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppressionROGERS, Christin C; ALLOWAY, Rita R; WOODLE, E. Steve et al.Transplantation. 2005, Vol 80, Num 1, pp 26-33, issn 0041-1337, 8 p.Article

Maltoma: A Helicobacter pylori-associated malignancy in transplant patientsAULL, Meredith J; BUELL, Joseph F; PEDDI, V. R et al.Transplantation. 2003, Vol 75, Num 2, pp 225-228, issn 0041-1337, 4 p.Article

Impact of hepatitis C virus status in pancreas transplantation: a case controlled studyHONAKER, Marsha R; STRATTA, Robert J; LO, Agnes et al.Clinical transplantation. 2002, Vol 16, Num 4, pp 243-251, issn 0902-0063Article